Tim Attebery, former American College of Cardiology and MedAxiom CEO, named Vxtra Health board chair

Vxtra Health, an Atlanta-based health insurance company focused on collaborating with physicians, has named Tim Attebery its new chairman of the board. Attbery has more than 30 years of experience in the healthcare industry, most recently serving as CEO for the American College of Cardiology (ACC) and MedAxiom.

“For over two decades, I have witnessed Tim's capacity to motivate physicians and inspire management teams to build sustainable trust in the marketplace by always focusing on what's best for patients,” Larry Hightower, Vxtra Health co-founder and CEO, said in a statement. “Tim's mission-driven leadership style aligns with our philosophy and will be equally inspiring to our team and our advisors as well as our clients who are committed to reducing costs, improving outcomes and providing a better experience for their employees.”

The announcement comes as Vxtra Health nears the launch of a line of “disruptive healthcare solutions” aimed at “self-funded, middle market employers” in two new markets.

Back in April, Attebery announced his resignation from the ACC and MedAxiom, calling it “the result of changing personal and family priorities.” Attebery has also served on the boards of the Cardiology Advocacy Alliance and Cardiology Leadership Alliance. He helped found both MedAxiom and the Society of Cardiovascular Computed Technology.

“Healthcare in America is experiencing, and will continue to experience, unprecedented change in the post-COVID-19 world,” Attebery said. “The market is in flux, and now is the time to accelerate and adopt new and innovative approaches. The marketplace is primed as never before for new payment models and new delivery strategies that will reduce waste and lower costs while improving the user-experience. Disruption is inevitable.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.